open access
An atypical cause leading to a diagnosis of acromegaly
Affiliations- Department of Endocrinology, National Institute of Endocrinology and Diabetology, Ľubochňa, Slovakia
- 1st Department of Internal Medicine, Comenius University Jessenius Faculty of Medicine, University Hospital Martin, Martin, Slovakia
open access
Abstract
Not required for Clinical Vignette.
Abstract
Not required for Clinical Vignette.
Keywords
acromegaly; heart failure; insulin-like growth factor 1; treatment
Supp./Additional Files (1)
About this articleTitle
An atypical cause leading to a diagnosis of acromegaly
Journal
Issue
Article type
Clinical vignette
Pages
385-386
Published online
2022-04-05
Page views
5014
Article views/downloads
423
DOI
Pubmed
Bibliographic record
Endokrynol Pol 2022;73(2):385-386.
Keywords
acromegaly
heart failure
insulin-like growth factor 1
treatment
Authors
Ivana Ságová
Milan Dragula
Marián Mokáň
Peter Vaňuga
References (4)- Ságová I, Pavai D, Kantárová D, et al. Influence of Disease Activity and Body Composition Parameters on Cross-Sectional Area of the Median Nerve in Acromegalic Patients. Physiol Res. 2021; 70(6): 921–929.
- Sharma MD, Nguyen AV, Brown S, et al. Cardiovascular Disease in Acromegaly. Methodist Debakey Cardiovasc J. 2017; 13(2): 64–67.
- Gadelha MR, Kasuki L, Lim DST, et al. Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update. Endocr Rev. 2019; 40(1): 268–332.
- Colao A, Pivonello R, Galderisi M, et al. Impact of treating acromegaly first with surgery or somatostatin analogs on cardiomyopathy. J Clin Endocrinol Metab. 2008; 93(7): 2639–2646.
